Drug discovery and development
The latest chemistry news and research on drug discovery and development, including cancer drugs, antibiotics, vaccines and drug screening, from the Royal Society of Chemistry's magazine, Chemistry World
-
ResearchClever chemistry turns antibiotic-resistant bacteria’s own defences against them
Photosensitiser is activated by enzyme linked to resistance, making bacteria vulnerable to light therapy
-
OpinionWhat kinds of reactions do you do most?
Variety may be the spice of life, but there’s space for the boring but effective
-
OpinionGSK agrees $10 billion deal for Nuvalent cancer drugs
Deal includes two late-stage molecules to augment GSK’s renewed cancer therapy pipeline
-
NewsCroatian researchers thrust into limelight as their 1990s’ peptide discovery goes mainstream in the US
Trump administration hopes to approve peptides popular with MAHA wellbeing advocates. How are the researchers at the centre of this coping with sudden media fame?
-
NewsWhat kind of damage has RFK Jr’s health department inflicted on vaccine research in the US so far?
Since becoming health secretary in early 2025, Robert F Kennedy Jr has confirmed the worst fears of his critics
-
BusinessUS FDA commissioner Makary resigns amid chaos and questions
Marty Makary’s departure, amid reports that Trump planned to fire him, is the result of an ‘inherited crisis’ and ‘shifting FDA standards’, BIO says
-
ArticleAdvantages of monodisperse PEG in drug development
Precision matters: why monodisperse PEG is transforming drug development.
-
Business‘Basic research is needed more than anything else’
Christian Hackenberger, co-founder of Tubulis, is excited that his team’s initial research is now creating clinical impact
-
PodcastVanadium-based medicines & sustainable labs
Vanadium-based medicines? We discuss the 23rd element’s little-known potential in pharmaceuticals. Plus, how labs across the UK are making achievable changes to increase their sustainability.
-
OpinionThe evolving landscape of pain drug discovery
Harnessing the power of human-relevant in vitro models
-
OpinionMajor drug regulators advancing routes to reduce animal testing
US, UK and EU all have goals to eliminate animal testing
-
OpinionWhen vanadium almost changed how we treat type 2 diabetes
Chris Orvig tells the story of BEOV
-
ResearchVanadium’s promise in medicine and the researchers who refuse to give up
It mimics phosphate, kills cancer cells in the lab and almost changed how we treat diabetes. So why has a vanadium compound never made it to the clinic?
-
OpinionIndia’s generic semaglutide surge
As patents on Novo Nordisk’s diabetes and weight loss blockbusters expire, generic makers have their versions ready
-
FeatureNew treatments offer hope for neglected snakebite victims
Nina Notman meets the scientists developing recombinant antivenoms and small molecule inhibitors to save the lives and limbs of snakebite patients, who number in the their hundreds of thousands
-
BusinessBoron plays a key role in new sleeping sickness drug
Acoziborole is the first single-dose treatment for both early and late stage sleeping sickness
-
FeatureCone snail venom peptides offer new hope for pain relief
Cone snails deploy sophisticated venom cocktails to paralyse prey. Anthony King talks to the researchers harnessing these peptides to develop new pain medications
-
WebinarTaking the sting out of pain: how marine venoms can be used to heal
Learn how marine venoms are being used to treat chronic pain
-
OpinionModerna’s vaccine regulatory hokey-cokey
US FDA initially refused to accept flu vaccine for review, but has since reversed that decision
-
WebinarHigh‑throughput retrosynthesis for real‑world chemistry
Discover how retrosynthesis software, paired with application programming interfaces, can accelerate route design, virtual screening and practical synthesis decisions